BILLY WALTON: Open Payments
NPI 1871980995 · WHITFIELD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,045 in 64 payments from 10 companies in 2025. Trend: 2023 $627 · 2024 $733 · 2025 $1,045
Food & beverage: $1,045
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 19 | $220 |
| E.R. Squibb & Sons, L.L.C. | 11 | $172 |
| Neurocrine BioSciences, Inc. | 10 | $152 |
| Axsome Therapeutics, Inc. | 7 | $135 |
| ABBVIE INC. | 5 | $133 |
| Vanda Pharmaceuticals Inc. | 3 | $68 |
| Alkermes, Inc. | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 4 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
Products named: COBENFY, REXULTI, INGREZZA, Auvelity, VRAYLAR, ABILIFY ASIMTUFII, FANAPT, ARISTADA.
Industry payments across MS — which companies pay providers there.
